Skip to content

TIDL-CONSENT-ECOMM-022 · v2.2 · Effective August 13, 2026 · Adapted from PRX-CONSENT-ECOMM-022

Consent for Electronic Communications

By accepting this Consent during intake, you consent to receive electronic communications from TIDL Health Inc, its Providers, and its Business Associates at the email address, mobile telephone number, and any other contact information you provide.

1Scope

Communications may include:

  • Treatment-related communications (appointment reminders, clinical messages, lab results, prescription status, shipping notifications)
  • Administrative and billing communications (invoices, payment confirmations, account notices)
  • Marketing communications (new services, promotions, educational content)

2Automated messages

Some messages may be sent using automated dialing systems, prerecorded voice, or SMS text. Standard message and data rates may apply. Your consent is not a condition of purchase or treatment.

3Opt-out

You may opt out of marketing communications at any time by replying STOP to SMS messages, clicking unsubscribe in emails, or contacting support@tidl.com. Opting out of marketing does not stop treatment-related communications required to deliver care.

Acceptance is captured during intake with timestamp, document version, IP address, and user agent when you check the optional communications box. Signature blocks are not completed on this public page.